In ischemic priapism caused by phosphodiesterase type 5 (PDE5) inhibitors, is the glans penis spared?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, in ischemic priapism from PDE5 inhibitors, the glans penis is characteristically spared.

In ischemic priapism, the corpora cavernosa are typically affected while the corpus spongiosum and glans penis are not involved 1. This anatomical pattern is a defining feature of the condition regardless of etiology, including PDE5 inhibitor-induced cases.

Anatomical Pattern in Ischemic Priapism

The physical examination findings are distinctive:

  • Corpora cavernosa: Fully rigid and tender
  • Glans penis: Soft and uninvolved
  • Corpus spongiosum: Unaffected

This pattern occurs because ischemic priapism is a compartment syndrome affecting only the paired corpora cavernosa, which become engorged with hypoxic, acidotic blood (PO2 <30 mm Hg, PCO2 >60 mm Hg, pH <7.25) 1.

Why the Glans is Spared

The glans receives its blood supply from terminal branches of the internal pudendal artery, providing redundant vascular supply that remains patent during the veno-occlusive process affecting the corpora cavernosa 2. The corpus spongiosum (which extends into the glans) has separate venous drainage that is not compromised in ischemic priapism.

Clinical Significance

This anatomical sparing is diagnostically important:

  • Helps differentiate ischemic from non-ischemic priapism: In non-ischemic priapism, the entire penis including the glans may show partial tumescence 1
  • Guides surgical intervention: Distal corporoglanular shunts work by creating a communication between the rigid corpora cavernosa and the unaffected glans/corpus spongiosum to allow drainage 1

The soft, uninvolved glans in the setting of rigid corpora cavernosa is a hallmark physical finding that should prompt immediate evaluation with corporal blood gas analysis 1.

Related Questions

In a male patient who combined phosphodiesterase‑5 inhibitors and now has a partially rigid penis with a soft, highly sensitive glans that partially softens when lying down over the past 48 hours, does this presentation represent ischemic priapism?
After taking combined phosphodiesterase‑5 inhibitors, I have a partially rigid, firm shaft with a red, sensitive glans—could this be ischemic priapism?
What are the possible causes of marked redness and hypersensitivity of the penis (especially the glans) in a patient with PDE‑5 inhibitor–induced priapism?
Can excessive use of phosphodiesterase‑5 inhibitors cause a hard‑flaccid condition?
Why can the patient still achieve erections one month after a prolonged ischemic priapism episode, given residual cavernous smooth‑muscle viability, arterial inflow, and prior PDE‑5 inhibitor use?
What changes in color and sensation occur in the glans during ischemic priapism?
Can you write a history and physical examination note for an 8‑year‑old male with an open distal phalangeal (Seymour) fracture of the left index finger?
In an adult patient on antidepressant therapy who reports reduced libido, erectile dysfunction, or delayed orgasm, what are the recommended treatment strategies for these sexual side effects?
Which vitamins can a generally healthy adult take to prevent the common cold?
What are the possible causes of marked redness and hypersensitivity of the penis (especially the glans) in a patient with PDE‑5 inhibitor–induced priapism?
What are the complication rates of ultrasound-guided thoracentesis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.